QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
CVE:ENTG

Entourage Health (ENTG) Stock Price, News & Analysis

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)
Free ENTG Stock Alerts
C$0.02
+0.01 (+50.00%)
(As of 03:51 PM ET)
Compare
Today's Range
C$0.01
▼
C$0.02
50-Day Range
C$0.01
▼
C$0.02
52-Week Range
C$0.01
▼
C$0.03
Volume
7,966 shs
Average Volume
90,329 shs
Market Capitalization
C$4.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlinesInsider Trades
ENTG stock logo

About Entourage Health Stock (CVE:ENTG)

Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. It offers cannabis plants, dried flower, pre-rolls, soft chews, chewing gum, cannabis oils, capsules, topicals and vapes, extracts, and edibles. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Syndicate Cannabis, Mary's Medicinals, and Irwin Naturals brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.

ENTG Stock Price History

ENTG Stock News Headlines

March 30, 2024 | yahoo.com
A Different Type of Entourage
January 30, 2024 | theglobeandmail.com
Closing Bell: Entourage Health Corp up on Tuesday (ENTG)
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
December 28, 2023 | theglobeandmail.com
Closing Bell: Entourage Health Corp up on Thursday (ENTG)
December 13, 2023 | theglobeandmail.com
Closing Bell: Entourage Health Corp down on Wednesday (ENTG)
December 5, 2023 | markets.businessinsider.com
Entourage Health Provides Corporate Update
November 29, 2023 | theglobeandmail.com
Entourage Health: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ENTG)
November 27, 2023 | theglobeandmail.com
Entourage Health: Top 25 Undervalued TSX Venture Exchange Stocks (ENTG)
April 19, 2024 | Behind the Markets (Ad)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
November 26, 2023 | theglobeandmail.com
Entourage Health: Top 10 Undervalued Drug Manufacturers Industry Stocks (ENTG)
November 8, 2023 | finance.yahoo.com
Entourage Health to Host Third Quarter 2023 Financial Results Call on November 28
October 10, 2023 | theglobeandmail.com
Closing Bell: Entourage Health Corp down on Friday (ENTG)
August 30, 2023 | finanznachrichten.de
Entourage Health Corp.: Entourage Health Reports Second Quarter 2023 Financial Results
August 30, 2023 | finance.yahoo.com
Entourage Health Reports Second Quarter 2023 Financial Results
August 30, 2023 | benzinga.com
Two Key Cannabis Trends Surged - Entourage Health's Financial Results Show Why
August 24, 2023 | finance.yahoo.com
Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis
August 21, 2023 | theglobeandmail.com
Closing Bell: Entourage Health Corp down on Monday (ENTG)
August 17, 2023 | theglobeandmail.com
Closing Bell: Entourage Health Corp up on Wednesday (ENTG)
August 9, 2023 | finance.yahoo.com
Entourage Health Announces Second Quarter 2023 Financial Results Call to be held on August 30
August 1, 2023 | finance.yahoo.com
Investors Aren't Entirely Convinced By Entourage Health Corp.'s (CVE:ENTG) Revenues
July 4, 2023 | finance.yahoo.com
Entourage Health Announces International Sale of Bulk Cannabis to Australia
June 19, 2023 | stockhouse.com
Entourage Health Announces Restructuring of Senior Secured Debt
June 14, 2023 | finance.yahoo.com
Entourage Health Announces Results of 2023 Annual General Meeting of Shareholders
May 30, 2023 | finanznachrichten.de
Entourage Health Corp.: Entourage Health Reports First Quarter 2023 Financial Results
May 30, 2023 | finance.yahoo.com
Entourage Health Reports First Quarter 2023 Financial Results
May 30, 2023 | msn.com
Entourage Health Q1 Revenue Declines 4.8% YoY, What About Adjusted EBITDA?
May 15, 2023 | finance.yahoo.com
Entourage Health to Host First Quarter 2023 Earnings Conference Call
See More Headlines
Receive ENTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Entourage Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
4/29/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:ENTG
CUSIP
N/A
CIK
N/A
Web
www.entegris.com
Phone
19784366500
Fax
N/A
Employees
5,800
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-116,920,000.00
Net Margins
-296.29%
Pretax Margin
N/A
Return on Equity
-371.10%
Return on Assets
-24.18%

Debt

Debt-to-Equity Ratio
2,914.72
Current Ratio
0.20
Quick Ratio
0.91

Sales & Book Value

Annual Sales
C$39.46 million
Price / Sales
0.12
Cash Flow
C$0.01 per share
Price / Cash Flow
1.35
Book Value
C($0.42) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
308,390,000
Free Float
N/A
Market Cap
C$4.63 million
Optionable
Not Optionable
Beta
1.20
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. George Scorsis (Age 46)
    Executive Chair & CEO
    Comp: $541.1k
  • Ms. Vaani Maharaj
    Chief Financial Officer
  • Mr. James Afara
    Chief Operating Officer
  • Dr. Alexandre Sibilev
    Vice-President of Quality Assurance & Global Regulatory Compliance
  • Ms. Marianella DelaBarrera
    Senior Vice President of Communications & Corporate Affairs
  • Mr. Jeff Keyes
    Senior Vice President of Operations
  • Dr. Peter Blecher
    Chief Medical Officer
  • Mr. Joseph Mele
    Chief Commercial Officer
  • Pat Scanlon
    Head of Cultivation
  • Catherine Flaman
    Senior Director of Communications & Corporate Affairs

Key Competitors

View All Competitors

ENTG Stock Analysis - Frequently Asked Questions

How have ENTG shares performed in 2024?

Entourage Health's stock was trading at C$0.02 at the start of the year. Since then, ENTG stock has decreased by 33.3% and is now trading at C$0.01.
View the best growth stocks for 2024 here.

When is Entourage Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024.
View our ENTG earnings forecast.

How do I buy shares of Entourage Health?

Shares of ENTG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:ENTG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Your Money is Not Safe
American Alternative
SHOCKING Crypto Leak…
Crypto 101 Media